Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

153 trials

NCT06465810
Recruiting
Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
Not applicable · Canada, China, Germany, Spain, United Kingdom, United States · 72 sites
Registry update: 23 Sept 2026
NCT06907186
Recruiting
An Interventional Pilot Study to Investigate the Feasibility and Acceptance of a Structured Psychological Support Program for Patients, Caregivers, and Presymptomatic Carriers in Hereditary Transthyretin Amyloidosis With Cardiomyopathy
Not applicable · Italy · 1 site
Registry update: 6 Apr 2025
NCT06887283
Recruiting
Essen Amyloidosis Registry
Not applicable · Germany · 1 site
Registry update: 6 Nov 2026
NCT06799273
Recruiting
MECKI-Amyloidosis: Assessment of the Exercise Capacity and Prognosis of Patients with Cardiac Amyloidosis
Not applicable · Italy · 1 site
Registry update: 29 Jan 2025
NCT06342466
Recruiting
Bortezomib, Pomalidomide, Dexamethasone for Systemic AL Amyloidosis
Phase 2 · China · 1 site
Registry update: 30 Dec 2024
NCT06365060
Recruiting
Screening for AL Amyloidosis in Smoldering Multiple Myeloma
Not applicable · United States · 13 sites
Registry update: 26 Oct 2026
NCT06907836
Recruiting
Description of a Retrospective Cohort of Patients With Transthyretin Cardiac Amyloidosis (ATTR-CA) in Internal Medicine
Not applicable · France · 1 site
Registry update: 2 Apr 2025
NCT06318260
Recruiting
Haemodynamic Effects of Dobutamine in Patients With Wild-type Transthyretin Amyloid Cardiomyopathy (ATTRwt)
Phase 1/2 · Denmark · 1 site
Registry update: 1 Jun 2026
NCT07435168
Recruiting
CHEST-CA: Study of Chest Pain and Hidden Cardiac Amyloidosis
Not applicable · Denmark · 1 site
Registry update: 27 Feb 2026
NCT06158854
Recruiting
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving Etentamig (ABBV-383) as an Intravenous (IV) Infusion
Phase 1/2 · Australia, France, Greece, Italy, Japan, United States · 23 sites
Registry update: 13 May 2026
Conflicting statuses (not updated in the registry for 5 months)
NCT06197165
Recruiting
Amylo-Shiatsu-Acute-Chronic: Effects of Shiatsu on Symptoms and Quality of Life of Amyloidosis Patients
Not applicable · France · 1 site
Registry update: 15 Jan 2026
NCT06291805
Recruiting
Phenotyping and Characterization of wtATTR-CM (TRACE 1)
Not applicable · Denmark · 1 site
Registry update: 15 Aug 2025
NCT05145816
Recruiting
Phase 1/2a Study of Belantamab Mafodotin in Relapsed or Refractory AL Amyloidosis
Phase 1/2 · United States · 3 sites
Registry update: 19 Aug 2026
NCT06251778
Recruiting
NatiOnal Referral cenTEr Study of Transthyretin Amyloid Cardiomyopathy(ATTR) Patients on Tafamidis
Not applicable · Italy · 1 site
Registry update: 16 Apr 2026
NCT06096675
Recruiting
CAPACITY (Cardiac Amyloidosis and Physical ACtivITY) Study
Not applicable · United States · 1 site
Registry update: 21 Jul 2026
NCT06192979
Recruiting
Optimize First-line Treatment for AL Amyloidosis With t (11; 14)
Not applicable · China · 7 sites
Registry update: 7 Jul 2026
NCT06205953
Recruiting
A EUropean REgistry and Sample Sharing networK to Promote the Diagnosis and Management of Light Chain Amyloidosis (EUREKA)
Not applicable · Switzerland, Germany, Spain, Italy, Netherlands, Uruguay · 6 sites
Registry update: 16 Apr 2026
NCT06075823
Recruiting
Edge-to-edge Mitral Valve Repair in ATTR-CM
Not applicable · Austria, Germany, Italy · 10 sites
Registry update: 16 Oct 2026
NCT06128629
Recruiting
MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
Phase 3 · Argentina, Austria, Australia, Belgium, Brazil, Canada, Czechia, Germany, Denmark, Spain, France, United Kingdom, Hungary, Israel, Italy, Japan, South Korea, Mexico, Netherlands, Norway, New Zealand, Poland, Portugal, Sweden, Singapore, Taiwan, United States · 143 sites
Registry update: 4 Nov 2026
2023-504041-31-00
Recruiting
Effect of dapagliflozin on the quality of life and exercise capacity of patients with amyloid transthyretin cardiac amyloidosis: a pilot, phase 2b study
Phase 2 · Italy · 1 site
Registry update: 2 Dec 2024

Ordered by registry start date. Freshness and sponsorship never change the order.